Diverse compound libraries have become a necessity to drug discovery efforts around
            the world. Target specific computational methods and high-throughput screening programs
            have aided the search for bioactive compounds, however, inefficiencies remain for
            neglected and tropical diseases. Detailed knowledge of mechanisms of action and target
            proteins is limited for parasitic diseases like malaria and leishmaniasis. In order
            to effectively lead research programs in these areas, our lab has developed a small
            compound library with diversity that mimics the NCI Diversity Set and the AntiMarin
            natural products database. Specific activity exhibited by each compound against Plasmodium falciparum and Leishmania donovani has been overlain to create activity “hotspots”, which we hope to improve activity
            prediction methods for unknown natural products isolated in the future. Limitations
            in diversity remain in all three libraries, and appear to have properties resembling
            small (MW < 400) hydrophobic molecules like terpenes. Here we use active antileishmanial
            terpenoids isolated from Antarctic marine organisms as models to show expansion of
            overall diversity and future predictability of the library as a bioassay dereplication
            tool.